Functional Characterization and Classification of Frequent Low-Density Lipoprotein Receptor Variants

Abifadel, 2003, Mutations in PCSK9 cause autosomal dominant hypercholesterolemia, Nat Genet, 34, 154, 10.1038/ng1161

Beglova, 2004, Cooperation between fixed and low pH-inducible interfaces controls lipoprotein release by the LDL receptor, Mol Cell, 16, 281, 10.1016/j.molcel.2004.09.038

Bertolini, 2013, Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy, Atherosclerosis, 227, 342, 10.1016/j.atherosclerosis.2013.01.007

Brown, 1986, A receptor-mediated pathway for cholesterol homeostasis, Science, 232, 34, 10.1126/science.3513311

Culi, 2003, Boca, an endoplasmic reticulum protein required for wingless signaling and trafficking of LDL receptor family members in Drosophila, Cell, 112, 343, 10.1016/S0092-8674(02)01279-5

Culi, 2004, Boca-dependent maturation of beta-propeller/EGF modules in low-density lipoprotein receptor proteins, EMBO J, 23, 1372, 10.1038/sj.emboj.7600132

Chaves, 2001, Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population: influence of low-density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL, and high-density lipoprotein cholesterol, J Clin Endocrinol Metab, 86, 4926, 10.1210/jcem.86.10.7899

Chen, 1990, NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low density lipoprotein receptor, J Biol Chem, 265, 3116, 10.1016/S0021-9258(19)39742-X

Chmara, 2010, Molecular characterization of Polish patients with familial hypercholesterolemia: novel and recurrent LDLR mutations, J Appl Genet, 51, 95, 10.1007/BF03195716

Choumerianou, 2005, Familial hypercholesterolemia and response to statin therapy according to LDLR genetic background, Clin Chem Lab Med, 43, 793, 10.1515/CCLM.2005.134

Dancourt, 2010, Protein sorting receptors in the early secretory pathway, Annu Rev Biochem, 79, 777, 10.1146/annurev-biochem-061608-091319

Davis, 1987, Acid-dependent ligand dissociation and recycling of LDL receptor mediated by growth factor homology region, Nature, 326, 760, 10.1038/326760a0

Davis, 1986, The J.D. mutation in familial hypercholesterolemia: amino acid substitution in cytoplasmic domain impedes internalization of LDL receptors, Cell, 45, 15, 10.1016/0092-8674(86)90533-7

Dvir, 2012, Atomic structure of the autosomal recessive hypercholesterolemia phosphotyrosine-binding domain in complex with the LDL-receptor tail, Proc Natl Acad Sci USA, 109, 6916, 10.1073/pnas.1114128109

Ellgaard, 1999, Setting the standards: quality control in the secretory pathway, Science, 286, 1882, 10.1126/science.286.5446.1882

Etxebarria, 2012, Functional characterization of splicing and ligand-binding domain variants in the LDL receptor, Hum Mutat, 33, 232, 10.1002/humu.21630

Fass, 1997, Molecular basis of familial hypercholesterolaemia from structure of LDL receptor module, Nature, 388, 691, 10.1038/41798

Goldstein, 2001, Familial hypercholesterolemia

Gudnason, 1999, Hyperhomocysteinaemia, genetics and cardiovascular disease risk, Eur Heart J, 20, 552

Hobbs, 1992, Molecular genetics of the LDL receptor gene in familial hypercholesterolemia, Hum Mutat, 1, 445, 10.1002/humu.1380010602

Hoeg, 1993, Homozygous familial hypercholesterolemia: a paradigm for phenotypic variation, Am J Cardiol, 72, 11D, 10.1016/0002-9149(93)90004-V

Holla, 2009, Nonsense-mediated decay of human LDL receptor mRNA, Scand J Clin Lab Invest, 69, 409, 10.1080/00365510802707163

Innerarity, 1990, Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia, J Lipid Res, 31, 1337, 10.1016/S0022-2275(20)42605-7

Jensen, 1999, Linking genotype to aorto-coronary atherosclerosis: a model using familial hypercholesterolemia and aorto-coronary calcification, Ann Hum Genet, 63, 511, 10.1046/j.1469-1809.1999.6360511.x

Jeon, 2001, Implications for familial hypercholesterolemia from the structure of the LDL receptor YWTD-EGF domain pair, Nat Struct Biol, 8, 499, 10.1038/88556

Kotze, 1993, Intrafamilial variability in the clinical expression of familial hypercholesterolemia: importance of risk factor determination for genetic counselling, Clin Genet, 43, 295, 10.1111/j.1399-0004.1993.tb03821.x

Leigh, 2008, Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolemia database, Ann Hum Genet, 72, 485, 10.1111/j.1469-1809.2008.00436.x

Leren, 1995, Is responsiveness to lovastatin in familial hypercholesterolaemia heterozygotes influenced by the specific mutation in the low-density lipoprotein receptor gene?, Eur J Clin Invest, 25, 967, 10.1111/j.1365-2362.1995.tb01975.x

Leren, 1997, Molecular genetics of familial hypercholesterolaemia in Norway, J Intern Med, 241, 185, 10.1046/j.1365-2796.1997.78119000.x

Marduel, 2010, Molecular spectrum of autosomal dominant hypercholesterolemia in France, Hum Mutat, 31, E1811, 10.1002/humu.21348

Miltiadous, 2006, Plasma lipoprotein(a) levels and LDL-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolemia, Ann Clin Lab Sci, 36, 353

Mozas, 2004, Molecular characterization of familial hypercholesterolemia in Spain: identification of 39 novel and 77 recurrent mutations in LDLR, Hum Mutat, 24, 187, 10.1002/humu.9264

Palacios, 2012, Molecular characterization of familial hypercholesterolemia in Spain, Atherosclerosis, 221, 137, 10.1016/j.atherosclerosis.2011.12.021

Rudenko, 2002, Structure of the LDL receptor extracellular domain at endosomal pH, Science, 298, 2353, 10.1126/science.1078124

Sorensen, 2006, Retention of mutant low density lipoprotein receptor in endoplasmic reticulum (ER) leads to ER stress, J Biol Chem, 281, 468, 10.1074/jbc.M507071200

Soutar, 2007, Mechanisms of disease: genetic causes of familial hypercholesterolemia, Nat Clin Pract Cardiovasc Med, 4, 214, 10.1038/ncpcardio0836

Springer, 1998, An extracellular beta-propeller module predicted in lipoprotein and scavenger receptors, tyrosine kinases, epidermal growth factor precursor, and extracellular matrix components, J Mol Biol, 283, 837, 10.1006/jmbi.1998.2115

Strom, 2011, Characterization of residues in the cytoplasmic domain of the LDL receptor required for exit from the endoplasmic reticulum, Biochem Biophys Res Commun, 415, 642, 10.1016/j.bbrc.2011.10.127

Sudhof, 1985, The LDL receptor gene: a mosaic of exons shared with different proteins, Science, 228, 815, 10.1126/science.2988123

Tolleshaug, 1982, Posttranslational processing of the LDL receptor and its genetic disruption in familial hypercholesterolemia, Cell, 30, 715, 10.1016/0092-8674(82)90276-8

Tosi, 2007, Genetic defects causing familial hypercholesterolaemia: identification of deletions and duplications in the LDL-receptor gene and summary of all mutations found in patients attending the Hammersmith Hospital Lipid Clinic, Atherosclerosis, 194, 102, 10.1016/j.atherosclerosis.2006.10.003

Van Hoof, 2005, Intracellular fate of LDL receptor family members depends on the cooperation between their ligand-binding and EGF domains, J Cell Sci, 118, 1309, 10.1242/jcs.01725

Vohl, 2002, Influence of LDL receptor gene mutation and apo E polymorphism on lipoprotein response to simvastatin treatment among adolescents with heterozygous familial hypercholesterolemia, Atherosclerosis, 160, 361, 10.1016/S0021-9150(01)00584-6

Vuorio, 1995, Heterozygous familial hypercholesterolaemia: the influence of the mutation type of the low-density-lipoprotein receptor gene and PvuII polymorphism of the normal allele on serum lipid levels and response to lovastatin treatment, J Intern Med, 237, 43, 10.1111/j.1365-2796.1995.tb01138.x

Yamamoto, 1984, The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA, Cell, 39, 27, 10.1016/0092-8674(84)90188-0

Yokode, 1992, Cytoplasmic sequence required for basolateral targeting of LDL receptor in livers of transgenic mice, J Cell Biol, 117, 39, 10.1083/jcb.117.1.39